Charley Pride

Legendary country singer Charley Pride at his last interview.

Anyone who has ever listened to "Kiss an Angel Good Morning" knows who Charley Pride is. He was as American as "Burgers and Fries and Cherry Pies" and the darling of Nashville at a time when his picture was kept off albums because he was black. Regardless of his race, he became country music's first black superstar, the first African American performer to appear onstage at the Grand Ole Opry, and the first to be inducted into the Country Music Hall of Fame. 

But Charley also shares a distinction that caused his death. Being African American placed him at higher risk from COVID-19, and this virus caused his death. Progressive physicians like Dr. Peter McCullough from Baylor, Dr. Harvey Risch from Yale, Dr. George Fareed from Harvard, and most recently Dr. Pierre Kory from the University of Wisconsin, have demonstrated the near 100 percent effectiveness of early outpatient treatment using repurposed drugs — and they have shared this with the Nation via Senate Hearings in November and December.

Dr. Pierre Kory, in emotional testimony this week, declared, "You know who's dying here? It's our African American and Latino and elderly. It's some of the most disadvantaged and impoverished members of our society. They are dying at higher rates than anyone else. It's the most severe discrepancy I've seen in my medical career. And we are responsible for protecting those disadvantaged members. We have a special duty to provide countermeasures. The amount of evidence to show Ivermectin is lifesaving and protective is so immense, and the drug is so safe. It must be implemented — I'm asking the NIH to review our data and come up with recommendations."

Many doctors who have employed early outpatient treatment have found it to be 100 percent effective at preventing COVID-19 death — this author included. Dr. Brian Tyson used early outpatient treatment and saved 1,900 infected patients. The earlier the treatment is given, the better.

Dr. Pierre Kory stated that any deaths now, knowing that early outpatient treatment is lifesaving, are preventable. The Kory Count is the running tally of the number of COVID-19 deaths that could have been prevented using such early outpatient treatment. Dr. Peter McCullough asked the FDA to approve early outpatient treatment on November 19, 2020. No answer and no approval.

My patients receive it. None have died from COVID. Not a single one of Dr. Brian Tyson's patients who received it died. If Charley Pride had received it, would we be reading about his death today? I think not. 

How many more have to die before the FDA and CDC recognize and provide Emergency Use Authorization and guidance so that ALL physicians can use early outpatient treatment to save their patients? Will our country uphold its duty to protect the most impoverished and vulnerable in our society — our African Americans and Latinos?

Let us all join together and ask — no — let us insist that the FDA review Dr. Kory's data not tomorrow — but today — and issue guidance on early outpatient treatment. The FDA's official policy remains zero early outpatient treatment, which is unacceptable to me, my patients, and their families. It should be unacceptable to you as well.

Today's Kory Count stands at 45,591


Jeffrey Grolig

The “Kory Count” of preventable deaths with early outpatient treatment:


November 19:  Dr. Peter McCullough requests FDA approval in Senate Hearing


November 20:   1,952

November 21:   1,429

November 22:   843

November 23:   1,039

November 24:   2,209

November 25:   2,313

November 26:   1,179

November 27.   1,412

November 28:   1,192

November 29:    818

November 30:   1,265

December 1:     2,610

December 2:     2,885

December 3:     2,857

December 4:     2,637

December 5:     2,190

December 6:     1,111

December 7:     1,533

December 8:     2,821

December 8: Dr. Pierre Kory repeats request for approval of early outpatient treatment

December 9:    3,157

December 10:  2,937

December 11:  2,951

December 12:  2,251 including Charley Pride

By Justus R. Hope, M.D.

Author, Surviving Cancer, COVID-19, and Disease: The Repurposed Drug Revolution

(2) comments


I am happy to say that Dr. Pierre Kory's and Dr. George Fareed's Senate testimonies bore fruit yesterday when Dr. Kory, Dr. Paul Marik and Dr. Andrew Hill of the WHO were invited to speak before the NIH Committee on COVID-19 Treatment. On January 6th, these three physicians summarized the results of 18 peer-reviewed and randomized controlled trials that included over 2,100 patients showing benefits of Ivermectin in the treatment of COVID-19 in all stages of the disease - from prophylaxis, to early stage and also in late-stage illness. The benefits of early outpatient treatment were discussed and we hope this will result in Emergency Use Authorization for the treatments that have been recommended and championed by all these visionary doctors who truly care about patients. In particular, I would commend both Dr. Brian Tyson and Dr. George Fareed for setting an example nationally for other physicians to follow.


Thank you to Dr. Grolig, Dr. Kory, and all of the other doctors who have let the public know about this treatment that is saving lives but would save so many more if only the FDA would approve it. It must be extremely frustrating for you, but we are so grateful for this knowledge and will share it with others.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.